Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. [electronic resource]
Producer: 20030418Description: 1-5 p. digitalISSN:- 1522-1946
- Abciximab
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Antibodies, Monoclonal -- administration & dosage
- Catheters, Indwelling -- adverse effects
- Cohort Studies
- Dose-Response Relationship, Drug
- Equipment Failure
- Female
- Femoral Artery -- drug effects
- Humans
- Immunoglobulin Fab Fragments -- administration & dosage
- Male
- Middle Aged
- Myocardial Ischemia -- drug therapy
- Outcome Assessment, Health Care
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Glycoprotein GPIIb-IIIa Complex -- administration & dosage
- Postoperative Complications
- Retrospective Studies
- Time Factors
- Tirofiban
- Tyrosine -- administration & dosage
- Vascular Diseases -- etiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.